// SECTOR DOSSIER
Genetic Engineering Unicorns
Every Genetic Engineering unicorn we track — 1 private companies valued $1B or more, tiered by paper valuation. Combined balance sheet myth: $10B.
TIER 2 // PRIORITY TARGETS
// SECTOR DOSSIER
Every Genetic Engineering unicorn we track — 1 private companies valued $1B or more, tiered by paper valuation. Combined balance sheet myth: $10B.
TIER 2 // PRIORITY TARGETS